Answers are grounded in this paper and cite their sources.
A new screening method identifies colistin-resistant E. coli in large numbers of isolates, indicating global applicability for antimicrobial resistance monitoring.
Colistin resistance presents a major challenge in combating multidrug-resistant Gram-negative bacteria. To address this concern, a screening protocol employing the selective CHROMagar COL-APSE medium has been developed. This medium enables differentiation between colistin-susceptible and colistin-resistant E. coli strains based on growth characteristics and distinct colony coloration. The method is well-suited for screening large numbers of isolates, making it practical for routine surveillance efforts. Its applicability across both low- and middle-income countries (LMICs) and high-income countries (HICs) enhances its global relevance, offering a cost-effective and scalable tool for antimicrobial resistance monitoring. Additionally, a tailored spot-test protocol was developed to complement the CHROMagar screening, providing a rapid and adaptable approach for preliminary identification of resistant isolates.
No takes yet. Share an insight, caveat, or question.
Soe Yu Naing (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: